e-learning
resources
Vienna 2009
Monday, 14.09.2009
Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
V. Rossetti, S. Aliberti, P. Peyrani, F. M. Massari, F. Piffer, P. Castellotti, L. Ruvolo, M. Pappalettera, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America)
Source:
Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Session:
Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Session type:
Thematic Poster Session
Number:
2450
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Rossetti, S. Aliberti, P. Peyrani, F. M. Massari, F. Piffer, P. Castellotti, L. Ruvolo, M. Pappalettera, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America). Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP). Eur Respir J 2009; 34: Suppl. 53, 2450
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Influence of chronic cardiovascular diseases (CVD) on course and outcome of community-acquired pneumonia (CAP)
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013
Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept